Immunovant, Inc. (IMVT) has 14 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 8 sales totalling $2.9M. Most recent filing: Aug. 28, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 28, 2026 | Pande Atul Director | $52,260 | 4,500 | 0% | Yes | |
|
|
||||||
| July 24, 2026 | Pande Atul Director | $47,055 | 4,500 | 0% | Yes | |
|
|
||||||
| July 24, 2026 filed July 23, 2026 | Girao Tiago Chief Financial Officer | −$263,015 | 6,798 | −3% | No | |
|
|
||||||
| July 24, 2026 filed July 23, 2026 | Stout Jay S Chief Technology Officer | −$110,537 | 2,857 | −1% | No | |
|
|
||||||
| July 10, 2026 filed July 8, 2026 | Gloria Melanie Chief Operating Officer | −$80,532 | 2,036 | −1% | No | |
|
|
||||||
Showing the 5 most recent of 14 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free